Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.21 | N/A |
| PEG Ratio (TTM) | 3.79 | N/A |
| P/S Ratio (TTM) | 2.89 | N/A |
| P/B Ratio (TTM) | 1.75 | N/A |
| P/FCF Ratio (TTM) | 41.10 | N/A |
| Price to 5YR AVG Earnings Ratio | 27.25 | N/A |
| Price to 5YR AVG FCF Ratio | 22.39 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.32% | N/A |
| ROE (TTM) | 9.11% | N/A |
| Net Profit Margin (TTM) | 15.04% | N/A |
| ROIC 5YR AVG | 7.22% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 8.68% | 44.05% | 30.61% |
| Revenue | 0.90% | 21.02% | 15.86% |
| Net Income | 8.09% | 60.54% | 40.08% |
| Cash Flow | 137.09% | 23.22% | 3.05% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.53 | N/A |
| Quick Ratio (TTM) | 0.36 | N/A |
| D/E Ratio (TTM) | 0.60 | N/A |
| Interest Coverage (TTM) | 6.39 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.51 | N/A |
| LTL to 5YR AVG FCF | 5.81 | N/A |
| Shares Outstanding Growth 5YR AVG | 5.80% | N/A |